Gain Therapeutics Inc GANX:NASDAQ

RT Quote | Last NASDAQ LS, VOL From CTA | USD
Last | 05/10/24 EDT
2.51UNCH (UNCH)
Volume
106,469
52 week range
2.00 - 5.45
Loading...
  • Open2.70
  • Day High2.70
  • Day Low2.41
  • Prev Close2.51
  • 52 Week High5.45
  • 52 Week High Date05/12/23
  • 52 Week Low2.00
  • 52 Week Low Date11/22/23

Key Stats

  • Market Cap45.31M
  • Shares Out18.05M
  • 10 Day Average Volume0.13M
  • Dividend-
  • Dividend Yield-
  • Beta0.62
  • YTD % Change-23.12

KEY STATS

  • Open2.70
  • Day High2.70
  • Day Low2.41
  • Prev Close2.51
  • 52 Week High5.45
  • 52 Week High Date05/12/23
  • 52 Week Low2.00
  • 52 Week Low Date11/22/23
  • Market Cap45.31M
  • Shares Out18.05M
  • 10 Day Average Volume0.13M
  • Dividend-
  • Dividend Yield-
  • Beta0.62
  • YTD % Change-23.12

RATIOS/PROFITABILITY

  • EPS (TTM)-1.74
  • P/E (TTM)-1.44
  • Fwd P/E (NTM)-1.92
  • EBITDA (TTM)-22.17M
  • ROE (TTM)-141.57%
  • Revenue (TTM)55,179.998
  • Gross Margin (TTM)-
  • Net Margin (TTM)-40,354.33%
  • Debt To Equity (MRQ)4.51%

EVENTS

  • Earnings Date08/08/2024(est)
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest On Gain Therapeutics Inc

 

Profile

MORE
Gain Therapeutics, Inc. is a biotechnology company. The Company is focused on developing novel small molecule therapeutics to treat diseases across several therapeutic areas, including, central nervous system (CNS) disorders, lysosomal storage disorders (LSDs), metabolic disorders, and other diseases that can be targeted through protein degradation, such as oncology. The Company’s drug discovery platform, Magellan discovers novel allosteric binding sites on proteins...
Khalid Islam Ph.D.
Chairman of the Board, Founder
Matthias Alder
President, Chief Executive Officer, Director
Gene Mack
Chief Financial Officer, Company Secretary
Address
4800 Hampden Lane, Suite 200
Bethesda, MD
20814
United States

Top Peers

SYMBOLLASTCHG%CHG
INTS
Intensity Therapeutics Inc
4.00UNCHUNCH
AVRO
AVROBIO Inc
1.23UNCHUNCH
QTTB
Q32 Bio Inc
27.13UNCHUNCH
EYEN
Eyenovia Inc
0.7713UNCHUNCH
ANVS
Annovis Bio Inc
5.93UNCHUNCH